Third Harmonic Bio
THRD
THRD was delisted on the 30th of July, 2025.
100 hedge funds and large institutions have $134M invested in Third Harmonic Bio in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 29 closing their positions.
262% more call options, than puts
Call options by funds: $286K | Put options by funds: $79K
177% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 13
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
10% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 29
3% more funds holding
Funds holding: 97 → 100 (+3)
13.83% less ownership
Funds ownership: 99.76% → 85.93% (-14%)
71% less capital invested
Capital invested by funds: $463M → $134M (-$328M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$18.5M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$11.8M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.78M |
| 4 |
NM
Newtyn Management
New York
|
+$3.08M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
General Atlantic
New York
|
-$34.7M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$32.7M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$30.1M |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$20.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.3M |
THRD Hedge Fund Activity: Q1 2025 in Review
100 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q1 2025, worth a combined $134M — down 71% from $463M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new THRD positions and 29 closed out — a net gain of 3 holders — while 36 added to existing stakes and 13 trimmed.
The largest buyer was BML Capital Management, opening a new position worth an estimated $18.5M. The largest seller was General Atlantic, exiting entirely with an estimated $34.7M sold.
- 100 institutional investors held Third Harmonic Bio (THRD) as of Q1 2025, up from 97 in Q4 2024.
- Funds reported $134M of Third Harmonic Bio stock for Q1 2025, down 71% quarter-over-quarter.
- 32 funds opened new Third Harmonic Bio positions in Q1 2025 and 29 closed out, a net change of +3 holders.
- The largest Third Harmonic Bio buyer in Q1 2025 was BML Capital Management, an estimated $18.5M added.
- The largest Third Harmonic Bio seller in Q1 2025 was General Atlantic, an estimated $34.7M sold.
Based on aggregated 13F filings for Q1 2025.